A detailed history of Fjarde Ap Fonden transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Fjarde Ap Fonden holds 3,900 shares of BIO stock, worth $1.44 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,900
Previous 4,200 7.14%
Holding current value
$1.44 Million
Previous $1.36 Million 0.52%
% of portfolio
0.01%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$304.11 - $351.99 $91,233 - $105,597
-300 Reduced 7.14%
3,900 $1.35 Million
Q4 2023

Feb 14, 2024

BUY
$269.37 - $365.04 $26,937 - $36,504
100 Added 2.44%
4,200 $1.36 Million
Q3 2023

Oct 23, 2023

BUY
$350.25 - $422.63 $1.16 Million - $1.39 Million
3,300 Added 412.5%
4,100 $1.47 Million
Q1 2023

May 15, 2023

BUY
$418.69 - $503.0 $334,952 - $402,400
800 New
800 $383,000
Q2 2022

Aug 11, 2022

SELL
$463.67 - $597.16 $1.02 Million - $1.31 Million
-2,200 Reduced 41.14%
3,147 $1.56 Million
Q1 2022

May 13, 2022

SELL
$524.57 - $735.42 $526,143 - $737,626
-1,003 Reduced 15.8%
5,347 $3.01 Million
Q4 2021

Feb 15, 2022

SELL
$708.84 - $794.68 $177,210 - $198,670
-250 Reduced 3.79%
6,350 $4.8 Million
Q3 2021

Nov 15, 2021

SELL
$657.71 - $825.77 $197,313 - $247,731
-300 Reduced 4.35%
6,600 $4.92 Million
Q2 2021

Aug 12, 2021

SELL
$576.64 - $649.04 $115,328 - $129,808
-200 Reduced 2.82%
6,900 $4.45 Million
Q1 2021

May 17, 2021

BUY
$547.01 - $662.35 $328,206 - $397,410
600 Added 9.23%
7,100 $4.06 Million
Q4 2020

Feb 12, 2021

SELL
$510.68 - $643.45 $766,020 - $965,175
-1,500 Reduced 18.75%
6,500 $3.79 Million
Q2 2020

Aug 13, 2020

SELL
$334.87 - $493.06 $200,922 - $295,836
-600 Reduced 6.98%
8,000 $3.61 Million
Q1 2020

May 11, 2020

BUY
$320.01 - $409.07 $480,015 - $613,605
1,500 Added 21.13%
8,600 $3.02 Million
Q4 2019

Feb 10, 2020

BUY
$319.73 - $374.2 $2.27 Million - $2.66 Million
7,100 New
7,100 $2.63 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $9.09B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Fjarde Ap Fonden Portfolio

Follow Fjarde Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.